Vaccination and herd immunity: what more do we know?

scientific article

Vaccination and herd immunity: what more do we know? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QCO.0B013E328352F727
P698PubMed publication ID22561998

P50authorRobert BooyQ92264397
P2093author name stringHarunor Rashid
Gulam Khandaker
P433issue3
P921main subjectherd immunityQ736798
P304page(s)243-249
P577publication date2012-06-01
P1433published inCurrent Opinion in Infectious DiseasesQ15724406
P1476titleVaccination and herd immunity: what more do we know?
P478volume25

Reverse relations

cites work (P2860)
Q38108829A critical review and meta-analysis of the efficacy of whole-cell killed Tritrichomonas foetus vaccines in beef cattle.
Q37472929Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection
Q42250862An ethical analysis of mandatory influenza vaccination of health care personnel: implementing fairly and balancing benefits and burdens
Q93157098Bacterial meningitis in Sudanese children; critical evaluation of the clinical decision using clinical prediction rules
Q39248875Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru.
Q42278779Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?
Q34380025Development of Vi conjugate - a new generation of typhoid vaccine
Q26799527Dissecting the indirect effects caused by vaccines into the basic elements
Q38068468Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....
Q50957479Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis.
Q36276568Exploring pathways for building trust in vaccination and strengthening health system resilience.
Q30238724From Immunologically Archaic to Neoteric Glycovaccines
Q41918407Future research to underpin successful peste des petits ruminants virus (PPRV) eradication
Q33699581HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation
Q39241406Herd protection effect of N95 respirators in healthcare workers.
Q38146257In touch but not up-to-date: ambulatory visits and vaccination status in a cohort of young Swiss children
Q90353400Interventions to help people understand community immunity: A systematic review
Q34090191Invasive pneumococcal isolates from Danish infants (0 - 90 Days) during the years 1943 to 2013
Q55009161Measles-containing vaccination rates in southern Alberta.
Q55024731Metazoan Parasite Vaccines: Present Status and Future Prospects.
Q30376824Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.
Q38286377Particulate inorganic adjuvants: recent developments and future outlook
Q33772409Pneumococcal Vaccination Strategies. An Update and Perspective.
Q36125211Point: should childhood vaccination against measles be a mandatory requirement for attending school? Yes.
Q34348437Public trust and vaccine acceptance--international perspectives
Q34311615Resurgence of pertussis calls for re-evaluation of pertussis animal models
Q38407888Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines
Q36165265Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
Q98665101Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017
Q27468944Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
Q38616577The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Q38920259The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark
Q37465209The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination
Q91524738The privilege paradox: Geographic areas with highest socio-economic advantage have the lowest rates of vaccination
Q93169067Vaccine hesitancy : Report of a student study group
Q38806558Vaccine technologies: From whole organisms to rationally designed protein assemblies
Q40518553Victims, vectors and villains: are those who opt out of vaccination morally responsible for the deaths of others?

Search more.